Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells

N Martin-Orozco, Y Li, Y Wang, S Liu, P Hwu, YJ Liu… - Cancer research, 2010 - AACR
N Martin-Orozco, Y Li, Y Wang, S Liu, P Hwu, YJ Liu, C Dong, L Radvanyi
Cancer research, 2010AACR
Abstract CD4+ CD25+ Foxp3+ T-regulatory cells (Tregs) accumulate in tumors; however,
little is known about how the tumor environment influences this process. Here we show that
human melanomas express inducible T-cell costimulator ligand (ICOS-L/B7H) that can
provide costimulation through ICOS for the expansion of activated Tregs maintaining high
Foxp3 and CD25 expression as well as a suppressive function. Thus, ICOS-L expression by
melanoma tumor cells may directly drive Treg activation and expansion in the tumor …
Abstract
CD4+CD25+Foxp3+ T-regulatory cells (Tregs) accumulate in tumors; however, little is known about how the tumor environment influences this process. Here we show that human melanomas express inducible T-cell costimulator ligand (ICOS-L/B7H) that can provide costimulation through ICOS for the expansion of activated Tregs maintaining high Foxp3 and CD25 expression as well as a suppressive function. Thus, ICOS-L expression by melanoma tumor cells may directly drive Treg activation and expansion in the tumor microenvironment as another mechanism of immune evasion. Cancer Res; 70(23); 9581–90. ©2010 AACR.
AACR